How Long Does Semaglutide Take to Work?
The short answer is that it depends on what you mean by "work." Semaglutide does not change everything at once. It changes things in an order, and the order is fairly consistent even when the pace is not.
Appetite usually moves first. The scale follows, more slowly and less tidily. Lab markers move last, and take months to read. Knowing that sequence is what keeps the early weeks from feeling like failure. This page walks through it, explains why we do not publish an expected rate, and sets out what we check at each review. The main semaglutide page has the general picture.
First: appetite and "food noise"
The earliest change most people describe is not on the scale. It is in their head. The background loop that returns to food several times an hour goes quiet, and meals end sooner because fullness arrives sooner. People often put it as food taking up less space, which is a different thing from wanting food and resisting it.
There is research behind the description. In a 12-week trial of semaglutide run by Novo Nordisk, the manufacturer, people on the drug ate substantially less at a free-choice meal than people on placebo, and reported less hunger, fewer food cravings, better control of eating and less preference for high-fat foods. A 2026 survey of US adults using injectable semaglutide for weight, also funded by Novo Nordisk, found that agreement with statements describing food noise fell sharply after starting treatment. The survey asked people to recall how things were before, which its authors note can exaggerate the change, so it is a description of experience rather than a measurement. Both studied Novo Nordisk's semaglutide, not any compounded preparation.
For most people this shift shows up within the first weeks. For some it is obvious; for others it is subtle enough that they only notice it in hindsight, when they realize they forgot about a snack. Both are normal.
The same early weeks are when stomach side effects are most likely. So the first month or two is mostly about settling in and telling us how it is going. Semaglutide side effects covers what to expect and which signs need a call.
Then: the scale, over months
Weight follows appetite, but on a longer clock. It tends to show over months rather than weeks, and rarely in a straight line. Water, salt, constipation, a menstrual cycle, a heavy training week or a poor night's sleep can all move the number by more than a week's real change. A flat fortnight is common and is not a verdict.
The branded trials give a sense of the timescale. Wegovy's main weight trial in adults without diabetes, published as STEP 1, ran for 68 weeks, and its headline result was measured at the end of those 68 weeks, not at the end of the first few months. The Wegovy prescribing information charts average weight across that whole period. That is evidence about Wegovy in a trial setting, not a prediction for compounded semaglutide or for any individual, but it makes one useful point: this is a medicine judged over a year, not a month.
We do not publish an expected rate of loss for our compounded semaglutide, and we would be wary of anyone who does. The pace varies widely between people, with starting weight, age, sex, sleep, other medications and what else is going on in the plan all playing a part.
What we watch more closely than the rate is the composition. After 45, losing weight and losing the right weight are two different numbers, which is why body composition is measured, not assumed. Muscle and bone on semaglutide explains why.
Last: the labs
Blood markers are the slowest to move and the slowest to read. Your prescribing clinician reviews the labs this treatment depends on, comparing them against your baseline at review.
Some of that slowness is built into the tests. HbA1c, the usual measure of longer-term blood sugar, reflects the average over roughly the past two to three months, because that is how long red blood cells live. A change in diet and appetite this month will not show fully in HbA1c until well after. Lipids, liver markers and insulin resistance follow a similar months-long arc.
That is why the first lab recheck is a few months in, not a few weeks. Checking sooner mostly measures noise. The glossary entry on HbA1c explains the marker itself.
A rough shape of the first year
Described as experience rather than as any schedule, the first year tends to look like this:
- The first weeks: appetite quiets, meals get smaller, and stomach side effects are most likely. The scale may barely move.
- The first few months: side effects usually settle. Weight change becomes visible as a trend rather than a daily number. The first lab recheck happens.
- Six months to a year: the trend matters more than any single weigh-in. Body composition, labs and how you feel are read together, and the plan is adjusted around them.
None of this is a promise, and none of it describes how the medication itself is managed. That is individual and is decided with your clinician.
What we check at each review
Before you start. A baseline that typically covers blood sugar and insulin, lipids, kidney and liver function and thyroid, alongside weight and body composition, plus a full medication list. Your prescribing clinician uses it to decide whether semaglutide fits you at all.
At each review. How you are tolerating treatment: nausea, constipation, hydration, energy. What has happened to appetite, and whether you are eating enough protein and drinking enough. The weight trend, not the latest number. Any change in other medicines, because weight loss can change what a blood-pressure or diabetes medicine needs to do.
A few months in, and periodically after. Repeat labs against your baseline, sooner if something needs watching, and repeat body composition so that lean mass is tracked. Semaglutide labs and monitoring explains what each marker tells us.
When it seems not to be working
The commonest reason is time: weight has not caught up with appetite yet. The second is that the scale is hiding a real change, which is one reason we measure composition. The third is that something else is pulling the other way, such as a medication that promotes weight gain, poor sleep, thyroid function or a change in activity. Medications that cause weight gain covers the usual suspects.
If appetite has not changed at all after several weeks, or progress stalls for months, raise it at review rather than adjusting anything yourself. What happens next is a clinical decision.
Frequently asked questions
Appetite usually changes first, often within the first few weeks. Weight change tends to show over months rather than weeks, and lab markers such as blood sugar and lipids take months to read against your baseline. The pace varies widely between people, and we do not publish an expected rate of loss.
Most people notice appetite first: less background thinking about food, and feeling full sooner. Some notice it clearly within weeks; others only see it in hindsight. The scale usually lags behind. Stomach side effects are also most likely early, so the first weeks can feel mixed.
Food noise describes persistent, intrusive thoughts about food. Many people on semaglutide report it quietening, and a Novo Nordisk–funded 2026 survey of US users found agreement with food-noise statements fell sharply after starting. The survey relied on recall, so it describes experience rather than measuring it.
Often it is time: weight lags behind appetite. Sometimes the scale hides a real change in composition, or something else is working against it, such as another medication, sleep or thyroid function. Raise it at your review rather than changing anything yourself; the next step is a clinical decision.
Wegovy's STEP 1 trial in adults without diabetes ran for 68 weeks, and its headline result was measured at the end of that period. That is evidence about Wegovy in a trial, not a prediction for compounded semaglutide or for any one person, but it shows this is judged over a year.
Typically a few months in, then periodically, sooner if something needs watching. Earlier checks mostly measure noise: HbA1c, for example, reflects average blood sugar over roughly the past two to three months. Your prescribing clinician reviews the labs this treatment depends on against your baseline.
Where this fits in your plan
It starts with a baseline panel, because every later change is read against it. The Semaglutide Injection page covers how the medication is used here, and semaglutide vs tirzepatide covers the alternative.
We measure first. Then we act.
References
- Blundell J et al. Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes, Obesity and Metabolism 2017;19(9):1242–1251. https://pmc.ncbi.nlm.nih.gov/articles/PMC5573908/
- Arnaut T et al. Retrospective assessment of food noise changes after initiation of injectable semaglutide for weight management in the USA: the INFORM survey. Advances in Therapy 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC13415491/
- Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine 2021;384:989–1002. Abstract via Europe PMC: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:33567185%20AND%20SRC:MED&format=json&resultType=core
- Novo Nordisk. WEGOVY (semaglutide) injection and tablets, prescribing information (Clinical Studies, Study 2). Revised 06/2026. https://www.novo-pi.com/wegovy.pdf
- MedlinePlus. Hemoglobin A1C (HbA1c) test. US National Library of Medicine. https://medlineplus.gov/lab-tests/hemoglobin-a1c-hba1c-test/
- Back toSemaglutide Injection
- Semaglutide side effectsWhich semaglutide side effects come early and pass, which need a call the same day, and what the pancreas, gallbladder, thyroid and eye warnings mean.Read
- Semaglutide labs and monitoringThe labs worth having before semaglutide, when to recheck them, and what each marker tells the clinician who prescribes it.Read
- Muscle and bone on semaglutideHow much of the weight lost on semaglutide can be muscle, why that matters more after 45, and the training, protein and bone checks that protect it.Read
- GLP-1s and weight loss: FAQStraight answers on semaglutide and tirzepatide: compounded vs branded, oral vs injectable, side effects, muscle loss, plateaus and stopping.Read
How we write and review our content
ACT 2 Health provides clinician-led care. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. This content is educational and is not medical advice. Individual results vary.
All medical decisions are made solely by licensed healthcare professionals. Medications are prescribed only when medically necessary. GLP-1 medications are not suitable for everyone. Results may vary.
Compounded medication. Prepared by a licensed compounding pharmacy under a prescription written for you. Compounded medications are not FDA-approved, are not reviewed by the FDA for safety or effectiveness, and are not equivalent to or interchangeable with any branded product. Prescribed only when a licensed provider determines it is medically appropriate.
Care is delivered via telemedicine by healthcare professionals licensed in the state where the patient is located. Services are available only in states where our providers are licensed.